Plain-English translation of NCT07387796 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers want to understand what happens in your body and brain when you pause tirzepatide and then restart it. This study will ask you to temporarily stop taking the medication for about 3–4 weeks under medical supervision, then resume it for 6–8 weeks, while researchers track changes in your thinking, behavior, and brain activity through interviews, questionnaires, brain scans, and other assessments.
When people stop taking weight loss medications like this one, researchers don't fully understand what happens physically and psychologically—including changes in eating behavior, mood, and brain function. This trial aims to fill that gap so doctors can better prepare patients and support them if they need to pause or stop the medication.
You likely qualify if…
You likely don't qualify if…
You will have three main visits at the research clinic: one while you're currently taking the medication, one during your 3–4 week break from it, and one after you've restarted for 6–8 weeks. At each visit, you'll complete interviews, answer questionnaires, do some thinking tasks, have an MRI brain scan, and provide a stool sample. Between visits, you'll make two brief check-in phone calls and complete an online brain health assessment. All medication changes will be supervised by a study doctor to keep you safe.
AI-generated summary from trial data · Jul 2, 2026 · Not medical advice
United States